LONDON BROKER RATINGS: Barclays raises NatWest to 'overweight'
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
| Price | 407.20p on 19-10-2026 at 11:52:51 |
|---|---|
| Change | 0.80p 0.2% |
| Buy | 407.80p |
| Sell | 406.80p |
| Last Trade: | Buy 93.00 at 407.20p |
| Day's Volume: | 71,361 |
| Last Close: | 406.40p |
| Open: | 407.00p |
| ISIN: | GB00B2PDGW16 |
| Day's Range | 402.40p - 409.40p |
| 52wk Range: | 345.60p - 712.00p |
| Market Capitalisation: | £612.84m |
| VWAP: | 406.36865p |
| Shares in Issue: | 150.50m |
Wh Smith (SMWH) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 93 | 407.20p | Automatic Execution |
12:52:24 - 19-Oct-26 |
| Buy* | 101 | 407.00p | Automatic Execution |
12:52:23 - 19-Oct-26 |
| Buy* | 465 | 407.00p | Automatic Execution |
12:52:22 - 19-Oct-26 |
| Sell* | 219 | 406.80p | Automatic Execution |
12:52:22 - 19-Oct-26 |
| Buy* | 204 | 407.00p | Automatic Execution |
12:51:34 - 19-Oct-26 |
| Buy* | 67 | 407.00p | Automatic Execution |
12:51:34 - 19-Oct-26 |
| Buy* | 14 | 407.00p | Automatic Execution |
12:45:56 - 19-Oct-26 |
| Buy* | 12 | 407.00p | Automatic Execution |
12:41:37 - 19-Oct-26 |
| Buy* | 265 | 406.80p | Automatic Execution |
12:39:02 - 19-Oct-26 |
| Buy* | 311 | 406.80p | Automatic Execution |
12:39:02 - 19-Oct-26 |
Wh Smith (SMWH) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Oct 2026 7:00 am | RNS | Total Voting Rights |
| 16th Sep 2026 7:00 am | RNS | Pre-close Trading Update |
| 1st Sep 2026 7:00 am | RNS | Total Voting Rights |
| 10th Aug 2026 4:27 pm | RNS | Director/PDMR Shareholding |
| 3rd Aug 2026 7:00 am | RNS | Total Voting Rights |
| 30th Jun 2026 1:02 pm | RNS | Total Voting Rights |
| 30th Jun 2026 12:59 pm | RNS | Admission to Trading |
| 30th Jun 2026 12:53 pm | RNS | Holding(s) in Company |
| 29th Jun 2026 12:17 pm | RNS | Director/PDMR Shareholding |
| 10th Jun 2026 6:00 pm | RNS | Director/PDMR Shareholding |